Combination Treatment for Advanced Liver Cancer
The purpose of this study is to determine whether TACE combined endovascular stent implantation confers a survival benefit over TACE alone.
Hepatocellular Carcinoma|Hepatic Portal Vein Tumor Invasion
PROCEDURE: chemoembolization|DEVICE: endovascular stents implantation|PROCEDURE: iodine-125 seed strand implantation
Median survival time, 2 years
Time to Disease Progression, 2 years
The purpose of this study is to determine whether TACE combined endovascular stent implantation confers a survival benefit over TACE alone.